Qiming U.S. Ventures Management, LLC

Q1 2025 13F Holdings

  • Location
    bellevue, WA
  • Num holdings

    6

  • Value ($000)

    $23,103

  • Date Filed
    05/15/2025
  • Form type
    13F-HR
  • CIK
    0001909617
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

TOURMALINE BIO INC

COM
89157D105
$11.28M
49 %

741,691

KRRO
KRRO

KORRO BIO INC

COM
500946108
$6.41M
28 %

368,085

JSPR
JSPR

JASPER THERAPEUTICS INC

COM NEW
471871202
$3.99M
17 %

928,964

HLVX
HLVX

HILLEVAX INC

COM
43157M102
$540.29K
2 %

372,615

VTYX
VTYX

VENTYX BIOSCIENCES INC

COM
92332V107
$474.06K
2 %

412,225

---

KEZAR LIFE SCIENCES INC

COM NEW
49372L209
$404.41K
2 %

82,871

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 6 of 6